U-Chart Analysis:Shionogi & Co.,Ltd.:4507

※The values of financial statements might be different from the actual ones. Please confirm the original. [instructions]

Main FunctionHelp Company NameHelp CodeHelp Types of IndustryHelp Market Name Fiscal Year End Year of Listing
Browse U-Chart Add to 'Companies Comparison' list Compare Lustrum Ullet index Shionogi & Co.,Ltd. Go to web site 4507 Medicals 東証プライム March 1, 2000 1949.
Analysis u.gifU-Chart AnalysisHelp hikaku.gifAdd to 'Companies Comparison' listHelp u2.gifCompare LustrumHelp mark.gifUllet indexHelp
Accounts Information Balance Sheet Profit and Loss Account Cash Flow Statement
Display

Shionogi & Co.,Ltd. Balance Sheet(B/S)

[Show - Hide] U-Chart:Balance Sheet (B/S)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Shionogi & Co.,Ltd. Balance Sheet 2025年3月期 Shionogi & Co.,Ltd. Balance Sheet 2024年3月期 Shionogi & Co.,Ltd. Balance Sheet 2023年3月期 Shionogi & Co.,Ltd. Balance Sheet 2022年3月期 Shionogi & Co.,Ltd. Balance Sheet 2021年3月期

[Show - Hide] Balance Sheet (B/S)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Cash and Cash Equivalents 374,795 358,090 309,224 254,420 276,173
Other Current AssetsHelp 483,709 426,115 474,968 404,785 280,065
Tangible Fixed AssetsHelp 134,807 124,026 118,567 112,417 95,710
Intangible Fixed AssetHelp 143,652 117,621 96,309 81,223 76,558
Investments and OthersHelp 382,638 375,779 302,913 288,118 261,129
Total AssetsHelp 1,535,349 1,416,918 1,311,800 1,150,601 998,992
Total Current LiabilitiesHelp 155,006 172,839 205,357 171,211 143,034
Total Long-term LiabilitiesHelp 18,418 8,753 6,397 3,729 9,850
Shareholder's EquityHelp 1,361,925 1,235,326 1,100,046 975,661 846,108
Total LiabilitiesHelp 1,535,349 1,416,918 1,311,800 1,150,601 998,992

Shionogi & Co.,Ltd. Profit and Loss Account(P/L)

[表示非表示] U-Chart:Profit and Loss Account (P/L)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Shionogi & Co.,Ltd. Profit and Loss Account 2025年3月期 Shionogi & Co.,Ltd. Profit and Loss Account 2024年3月期 Shionogi & Co.,Ltd. Profit and Loss Account 2023年3月期 Shionogi & Co.,Ltd. Profit and Loss Account 2022年3月期 Shionogi & Co.,Ltd. Profit and Loss Account 2021年3月期

[Show - Hide] Profit and Loss Account (P/L)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Amount of Sales 438,268 435,081 426,684 335,138 297,177
Total Sales 438,268 435,081 426,684 335,138 297,177
Cost of SalesHelp 63,826 57,602 62,246 55,415 52,523
Other Costs and RevenueHelp 204,007 215,449 179,473 165,538 132,795
Total CostsHelp 267,833 273,051 241,719 220,953 185,318
Net RevenueHelp 374,442 377,479 364,438 279,723 244,654
Earnings Before TaxHelp 200,750 198,283 220,332 126,268 143,018
Net IncomeHelp 170,435 162,030 184,965 114,185 111,859
Net Income 170,435 162,030 184,965 114,185 111,859

Shionogi & Co.,Ltd. Cash Flow Statement(C/F)

[表示非表示] U-Chart:Cash Flow Statement (C/F)Help Icon

【Left:Outgoing Money】 【Right:Incoming Money】

Shionogi & Co.,Ltd. Cash Flow Statement 2025年3月期 Shionogi & Co.,Ltd. Cash Flow Statement 2024年3月期 Shionogi & Co.,Ltd. Cash Flow Statement 2023年3月期 Shionogi & Co.,Ltd. Cash Flow Statement 2022年3月期 Shionogi & Co.,Ltd. Cash Flow Statement 2021年3月期

[Show - Hide] Cash Flow Statement (C/F)Help  ※Unit:Millions of Yen

Accounting Date March 31, 2025 March 31, 2024 March 31, 2023 March 31, 2022 March 31, 2021
Operating Cash Flow(OFC)Help 195,459 154,285 177,866 102,068 109,039
Investing Cash Flow(ICF)Help -116,080 5,922 -48,292 -96,204 -5,261
Financing Cash FlowHelp -64,908 -126,853 -84,123 -36,615 -43,891
Exchange Difference of Cash and Cash EquivalentsHelp 2,233 15,512 9,352 8,998 7,425
Net Increase and Decrease in Cash and Cash Equivalentsn 16,704 48,866 54,803 -21,753 67,312

他社比較Help

Companies in 'Companies Comparison' list

Browsing historyHelp

Your reecently viewed companies

Shionogi & Co.,Ltd.

Company where related level is highHelp

TAISHO PHARMACEUTICAL CO.,LTD.
SSP CO.,LTD.
LTT Bio-Pharma Co.,Ltd.
Immuno-Biological Laboratories Co., Ltd.
CanBas Co.,Ltd.
Sanko Junyaku Co.,Ltd.
D.Western Therapeutics Institute, Inc.
Chordia Therapeutics
TMS Co.,Ltd.
NIPPON CHEMIPHAR CO.,LTD.